Charles River Laboratories | CRL - Market Capitalization


Charles River Laboratories reported $17.81B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 39.08B 6.43B Jun/2026
Align Technology USD 10.33B 1.75B Sep/2026
Bio-Rad Laboratories USD 8.71B 840M Nov/2026
Bruker USD 9.68B 181M Nov/2026
Cardinal Health USD 64.82B 13.29B Nov/2026
Charles River Laboratories USD 16.69B 2.7B Nov/2026
Cigna USD 83.86B 12.03B Nov/2026
Concord Medical Services Hldg CNY 117.2M 61.02M Dec/2025
CVS Health USD 100.62B 8.97B Nov/2026
Danaher USD 157.81B 18.96B Sep/2026
Dentsply International USD 2.09B 326M Nov/2026
Elevance Health USD 84.32B 340M Sep/2026
Humana USD 51.1B 3.41B Nov/2026
Illumina USD 37.12B 3.64B Nov/2026
Incyte USD 24.6B 1.95B Sep/2026
IQVIA Holdings USD 48.06B 3.81B Nov/2026
Laboratory Of America USD 24.99B 2.03B Sep/2026
Lakefront Biotherapeutics EUR 1.73B 2.64M Jun/2026
Lonza CHF 39.68B 980.61M Jun/2025
McKesson USD 140.53B 40.99B Nov/2026
Merck EUR 18.98B 27.8B Jun/2026
Mettler Toledo International USD 36.07B 5.79B Nov/2026
Novartis USD 292.09B 51.5B Sep/2026
Pfizer USD 165.12B 1.71B Nov/2026
Quest Diagnostics USD 25.72B 2.26B Sep/2026
Revvity USD 19.52B 2.61B Nov/2026
Thermo Fisher Scientific USD 249.58B 58.93B Sep/2026
United Therapeutics USD 28.64B 5.4B Nov/2026
UnitedHealth USD 329.49B 47.96B Sep/2026
Veradigm USD 525M 621M Mar/2026
Waters USD 27.52B 14.26B Nov/2026
West Pharmaceutical Services USD 26.09B 730M Sep/2026